Related Experiment Video

Updated: May 28, 2025

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

6.7K

Investigating the role of exosomal long non-coding RNAs in drug resistance within female reproductive system cancers

Nooshafarin Shirani1, Neda Abdi1, Matin Chehelgerdi2,3

  • 1Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.

Frontiers in Cell and Developmental Biology
|February 10, 2025
PubMed

Insights

Exosomes carrying long non-coding RNAs (lncRNAs) drive cancer drug resistance. Targeting these exosomal lncRNAs offers a promising strategy to overcome resistance and improve treatment outcomes in reproductive cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Exosomes are key mediators of intercellular communication.
  • Exosomes play a significant role in cancer progression and drug resistance.
  • Long non-coding RNAs (lncRNAs) are increasingly implicated in cancer development.

Purpose of the Study:

  • To review the emerging evidence linking exosomal lncRNAs to drug resistance mechanisms in cancers.
  • To synthesize current research on how exosomal lncRNAs influence cancer cell survival, tumor microenvironment, and chemotherapy efficacy.
  • To highlight potential therapeutic strategies targeting exosomal lncRNAs for overcoming drug resistance.

Main Methods:

  • Literature review and synthesis of current research findings.
  • Analysis of studies focusing on exosomal lncRNAs in ovarian, cervical, and endometrial cancers.
  • Exploration of the molecular mechanisms by which exosomal lncRNAs modulate drug resistance.

Main Results:

  • Exosomal lncRNAs are involved in modulating cancer cell survival and proliferation.
  • These molecules influence the tumor microenvironment, affecting treatment efficacy.
  • Specific exosomal lncRNAs have been identified as key players in conferring resistance to various chemotherapeutic agents.

Conclusions:

  • Exosomal lncRNAs represent a novel mechanism driving cancer drug resistance.
  • Targeting exosomal lncRNAs presents a promising therapeutic avenue for overcoming drug resistance in reproductive cancers.
  • Further research into exosomal lncRNA-mediated resistance could lead to improved patient outcomes.
Keywords:
chemotherapy efficacydrug resistanceexosomesfemale reproductive system cancerslong non-coding RNAstargeted therapiestumor microenvironment

More Related Videos

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

13.6K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.6K

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.3K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
55.9K